PMID: 9645829Jun 30, 1998Paper

Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program

Archives of Internal Medicine
M PahorW B Applegate

Abstract

It is expected that the treatment of hypertension in patients with renal disease decreases the risk of cardiovascular events, but the evidence in these patients is lacking. To assess the effect of diuretic-based treatment on cardiovascular events in patients with isolated systolic hypertension and renal dysfunction. A total of 4336 persons aged 60 years and older with systolic blood pressures of 160 mm Hg and higher and diastolic blood pressures of less than 90 mm Hg were randomly assigned to receive either placebo or chlorthalidone (12.5-25.0 mg/d), with the addition of atenolol (25-50 mg/d) or reserpine (0.05-0.10 mg/d) if needed, and observed for 5 years. The risk of first-occurring cardiovascular events, including stroke, transient ischemic attack, myocardial infarction, heart failure, coronary artery bypass surgery, angioplasty, aneurysm, endarterectomy, sudden death, or rapid death, was stratified according to baseline serum creatinine levels (35.4-84.0, 84.1-101.6, 101.7-119.3, and 119.4-212.2 micromol/L [0.4-0.9, 1.0-1.1, 1.2-1.3, and 1.4-2.4 mg/dL]). Systolic blood pressure reduction was not affected by baseline serum creatinine levels. Active treatment did not affect the risk of serum creatinine levels becoming elevat...Continue Reading

Associated Clinical Trials

Citations

Oct 16, 2003·Current Cardiology Reports·Bernard Waeber
Jul 8, 2003·Current Hypertension Reports·Bernard Waeber
Nov 6, 2004·Current Hypertension Reports·Gary E Sander
Sep 15, 2000·Journal of the American College of Cardiology·P A McCulloughS Borzak
Apr 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R VanholderUNKNOWN European Uremic Toxin Work Group
Sep 11, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Biagio Di IorioAntonio Bellasi
Aug 10, 2004·Current Opinion in Nephrology and Hypertension·Julián SeguraLuis M Ruilope
Jul 2, 2002·The American Journal of Geriatric Cardiology·G E Sander
Jul 12, 2012·International Journal of Clinical Practice·R HajhosseinyD J Goldsmith
Dec 5, 2009·Clinical and Experimental Nephrology·UNKNOWN Japanese Society of Nephrology
Mar 15, 2006·Kidney International·B R HemmelgarnB F Culleton
Apr 28, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Luca De NicolaUNKNOWN investigators of the TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group
Jul 14, 2005·Fundamental & Clinical Pharmacology·Julian Segura, Luis M Ruilope
Nov 22, 2005·Seminars in Nephrology·Luca De NicolaUNKNOWN Investigators of TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group
Sep 6, 2005·Primary Care·Michael MaddensAyham Ashkar
Jun 15, 2007·Journal of the American College of Cardiology·Keith A A FoxEugene Braunwald
Dec 21, 2016·The Cochrane Database of Systematic Reviews·Sandy D Shamon, Marco I Perez
Aug 18, 2004·Journal of Hypertension·Julian SeguraAlberto Zanchetti
Oct 6, 2010·Hypertension·John M FlackUNKNOWN International Society on Hypertension in Blacks
Jun 2, 2006·Journal of the American Society of Nephrology : JASN·Marcello TonelliAmit X Garg
Mar 6, 2004·Journal of Human Hypertension·G LeonciniR Pontremoli
Mar 19, 2003·Seminars in Dialysis·Bruce F Culleton, Brenda R Hemmelgarn
Feb 28, 2021·Kidney International·UNKNOWN Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group
Aug 23, 2002·Journal of the American Society of Nephrology : JASN·Peter W De LeeuwUNKNOWN Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
Jun 29, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Roberto MinutoloGiuseppe Conte

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.